Skip to content

Use of a Nurse Pain Educator for Patients With Chronic Pain

A Multicenter Study Comparing the Patient Outcomes Associated With Use of a Nurse Pain Educator for Patients With Chronic Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03044522
Enrollment
183
Registered
2017-02-07
Start date
2016-11-14
Completion date
2017-11-21
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Nurse's Role, Opioid Use

Brief summary

This multicenter randomized (block randomization) controlled parallel arm pilot study comparing the incorporation vs no incorporation of a Nurse Pain Educator into clinics that treat chronic non cancer pain patients with opioid analgesics. Subjects who are either opioid naïve or opioid experienced will be enrolled into the study.

Detailed description

The Nurse Pain Educator arm shall have two phases: a Pre-Teaching Phase and a Teaching/Knowledge Maintenance Phase. During the Pre-Teaching Phase, all subjects who are enrolled will complete different baseline assessments and will be prescribed an opioid. Subjects will then enter the Teaching/Knowledge Maintenance Phase. Subject enrolled into the Nurse Pain Educator arm will be educated on different opioid pain management topics with a focus on safe and appropriate use and consumption of opioid analgesics. Subjects will meet monthly with the Nurse Educator for up to 5 months for reinforcement of their training and to assess their use of their medication, their quality of life and their physical and mental well-being. Subjects who are enrolled into the study arm with no Nurse Pain Educator will be monitored every month to assess their use of their medication, their quality of life and their physical and mental well-being. No intervention will be conducted with these subjects beyond that of standard of care at the facility. Subjects will be evaluated monthly but primary differences in outcomes will compare baseline to 6 months.

Interventions

Sponsors

Food and Drug Administration (FDA)
CollaboratorFED
NEMA Research, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Ability to read, understand, and provide written informed consent * Male or Female patients ≥ 18 years of age * Diagnosed with non-cancer pain for \>3 months * Ability to meet study requirements (i.e., can attend monthly visits, able to complete questionnaires, etc.) * Prescribed an oral opioid that will last duration of the study period * Provide a completed Opioid Patient Prescriber Agreement

Exclusion criteria

* Diagnosed with chronic cancer pain * Personal or family history of alcohol or drug abuse in the past 5 years * Personal or family history of major mental illness

Design outcomes

Primary

MeasureTime frameDescription
Change Opioid Consumption6 MonthsDifference between opioid consumption in subjects with and without education by a Nurse Pain Educator as measured by a Qualitative Assessment of Opioid consumption from change in baseline to end of study and at each month.
Change in Opioid Consumption6 MonthsDifference between opioid consumption in subjects with and without education by a Nurse Pain Educator as measured by Total Morphine Sulfate Equivalent of Prescription from change in baseline to end of study and at each month.

Secondary

MeasureTime frameDescription
Change in Pain Medicine Questionnaire (PMQ)6 MonthsAssess Safe and Appropriate Use of Opioids by measuring change in Pain Medicine Questionnaire from baseline to end of study and at each month.
Change in Quality of Life Scale6 MonthsAssess Quality of Life and Daily Function by measuring the change in the 11 point Quality of Life Scale from baseline to end of study and at each month.
Change in SF-366 MonthsAssess Quality of Life and Daily Function by measuring the change in the SF-36 Health Outcomes survey from baseline to end of study and at each month.
Change in Current Opioid Misuse Measure (COMM)6 MonthsAssess Safe and Appropriate Use of Opioids by measuring change in Currenet Opioid Misuse Measure from baseline to end of study and at each month.

Other

MeasureTime frameDescription
Online Pain Assessment Tool6 MonthsAssess ease of use and outcomes of the Online Pain Assessment Tool from change in baseline to end of study in the Online Pain Assessment Tool scores

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026